- Home
- PRCT vs SRPT Comparison
PRCT vs SRPT Comparison
Compare PRCT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCT
- SRPT
- Stock Information
- Founded
- PRCT 2009
- SRPT 1980
- Country
- PRCT United States
- SRPT United States
- Employees
- PRCT N/A
- SRPT N/A
- Industry
- PRCT Medical Specialities
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- PRCT Health Care
- SRPT Health Care
- Exchange
- PRCT Nasdaq
- SRPT Nasdaq
- Market Cap
- PRCT 1.8B
- SRPT 1.9B
- IPO Year
- PRCT 2021
- SRPT 1997
- Fundamental
- Price
- PRCT $34.54
- SRPT $23.32
- Analyst Decision
- PRCT Buy
- SRPT Hold
- Analyst Count
- PRCT 8
- SRPT 31
- Target Price
- PRCT $67.14
- SRPT $40.61
- AVG Volume (30 Days)
- PRCT 1.0M
- SRPT 6.1M
- Earning Date
- PRCT 11-04-2025
- SRPT 11-05-2025
- Dividend Yield
- PRCT N/A
- SRPT N/A
- EPS Growth
- PRCT N/A
- SRPT N/A
- EPS
- PRCT N/A
- SRPT N/A
- Revenue
- PRCT $274,950,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- PRCT $48.38
- SRPT $9.41
- Revenue Next Year
- PRCT $30.87
- SRPT N/A
- P/E Ratio
- PRCT N/A
- SRPT N/A
- Revenue Growth
- PRCT 55.71
- SRPT 64.89
- 52 Week Low
- PRCT $32.11
- SRPT $10.42
- 52 Week High
- PRCT $103.81
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- PRCT 43.49
- SRPT 61.70
- Support Level
- PRCT $32.61
- SRPT $21.93
- Resistance Level
- PRCT $35.14
- SRPT $23.87
- Average True Range (ATR)
- PRCT 1.79
- SRPT 1.42
- MACD
- PRCT 0.14
- SRPT 0.09
- Stochastic Oscillator
- PRCT 55.35
- SRPT 68.94
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.